https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-23 / Ther Adv Med Oncol 2021;13:17588359211064653
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-23 / Ther Adv Med Oncol 2021;13:175883592110646532021-12-23 00:00:002021-12-23 00:00:00Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-17 / Hum Vaccin Immunother 2021 Dec;17(12):5563-5572
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-17 / Hum Vaccin Immunother 2021 Dec;17(12):5563-55722021-12-17 00:00:002021-12-17 00:00:00Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-16 / Front Oncol 2021;11:789078
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-16 / Front Oncol 2021;11:7890782021-12-16 00:00:002021-12-16 00:00:00Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-14 / Acta Radiol 2023 Jan;64(1):32-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-14 / Acta Radiol 2023 Jan;64(1):32-412021-12-14 00:00:002023-01-31 12:51:13Evaluation of response in patients with hepatocellular carcinoma treated with intratumoral dendritic cell vaccination using intravoxel incoherent motion (IVIM) MRI and histogram analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-03 / Clin Cancer Res 2021 Dec;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-03 / Clin Cancer Res 2021 Dec;2021-12-03 00:00:002021-12-03 00:00:00A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-982
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-9822021-11-24 00:00:002023-03-22 14:41:40Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-18 / Cancers (Basel) 2021 Nov;13(22)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-18 / Cancers (Basel) 2021 Nov;13(22)2021-11-18 00:00:002021-11-18 00:00:00A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-11 / Prostate 2021 Nov;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-11 / Prostate 2021 Nov;2021-11-11 00:00:002021-11-11 00:00:00Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-02 / Cancers (Basel) 2021 Nov;13(21)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-02 / Cancers (Basel) 2021 Nov;13(21)2021-11-02 00:00:002023-03-22 14:41:41Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-02 / Front Immunol 2021;12:770390
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-02 / Front Immunol 2021;12:7703902021-11-02 00:00:002021-11-02 00:00:00Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
